FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Approves Abbotts MitraClip

[ Price : $8.95]

FDA approves Abbotts catheter-based MitraClip therapy for treating patients suffering from mitral regurgitation.

Under Fire, FDA Panel Chair Withdraws Industry Presentation

[ Price : $8.95]

Responding to criticism, FDA Dermatologic and Ophthalmic Drugs Advisory Committee chair Lynn Drake withdraws her acceptance of an ...

FDA Approves Zogenix Opioid Pain Drug

[ Price : $8.95]

FDA has approved a Zogenix NDA for Zohydro ER (hydrocodone bitartrate extended-release capsules) for managing severe pain.

FDA Approves Cialis Label Addition

[ Price : $8.95]

FDA approves an Eli Lilly product label addition for Cialis (tadalafil) to include data from a 26-week study that showed Cialis 5 ...

CDER, Duke Plan Investigator Training

[ Price : $8.95]

Federal Register Notice: CDERs Office of Medical Policy and Duke University plan a training course for clinical investigators 11/1...

Animal Drug Regs Reflect July Approvals

[ Price : $8.95]

Federal Register Final rule: FDA amends the animal drug regulations to reflect July approval actions and also to reflect a sponsor...

Panel Backs Gileads Sofosbuvir for Hepatitis C

[ Price : $8.95]

An FDA advisory committee votes (15 to 0) to recommend approval of Gileads sofosbuvir to be used in combination with other agents ...

FDA Approves GE Healthcares Vizamyl

[ Price : $8.95]

FDA approves GE Healthcares Vizamyl (flutemetamol F 18 injection), a radioactive diagnostic drug for use with positron emission to...

FDA Backs Stricter Controls for Hydrocodone Combination Products

[ Price : $8.95]

FDA decides to recommend that hydrocodone combination products, such as Vicodin, be reclassified from Schedule III to Schedule II.

FDA Seeks Help in Tobacco Committee Selection

[ Price : $8.95]

Federal Register Notice: FDA seeks participants interested in helping to select nonvoting industry representatives on the Tobacco ...